Pawel Dokurno

9PUBLICATIONS
20CO-AUTHORS
Molecular targetsCheminformatics and quantitative structure-activity relationshipsBiomolecular modelling and design
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 12, 2026
Structure-Based Discovery of Potent BCL-XL Inhibitors through Rescaffolding.

|Dec 18, 2023
A covalent fragment-based strategy targeting a novel cysteine to inhibit activity of mutant EGFR kinase.

Naoki Kuki, David L Walmsley, Kazuo Kanai

|Sep 09, 2021
The Effect of Core Replacement on S64315, a Selective MCL-1 Inhibitor, and Its Analogues.

Szabolcs Sipos, Balázs Bálint, Zoltán B Szabó

|Jun 29, 2021
Design and Synthesis of Pyrrolo[2,3-d]pyrimidine-Derived Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors Using a Checkpoint Kinase 1 (CHK1)-Derived Crystallographic Surrogate.

Douglas S Williamson, Garrick P Smith, Gitte K Mikkelsen

|Jun 18, 2021
Fragment-Derived Selective Inhibitors of Dual-Specificity Kinases DYRK1A and DYRK1B.

David Lee Walmsley, James B Murray, Pawel Dokurno

|May 12, 2021
Structure-Guided Discovery of Potent and Selective DYRK1A Inhibitors.

Csaba Weber, Melinda Sipos, Attila Paczal

Pageof 2

Frequent Collaborators

7 joint publications

James Murray

7 joint publications

Allan Surgenor

6 joint publications

András Kotschy

4 joint publications

Ijen Chen